CASI Pharmaceuticals
CASI
#10174
Rank
HK$0.14 B
Marketcap
HK$7.07
Share price
-2.13%
Change (1 day)
-63.25%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): -HK$21.61

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$21.65. In 2024 the company made an earnings per share (EPS) of -HK$20.01 a decrease over its 2023 EPS that were of -HK$15.79.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$21.618.01%
2024-HK$20.0126.73%
2023-HK$15.79-32.89%
2022-HK$23.5211.9%
2021-HK$21.02-38.44%
2020-HK$34.15-8.96%
2019-HK$37.5150%
2018-HK$25.0177.78%
2017-HK$14.075.88%
2016-HK$13.29-22.73%
2015-HK$17.19-76.09%
2014-HK$71.90318.18%
2013-HK$17.19-71.79%
2012-HK$60.9665.96%
2011-HK$36.73-50%
2010-HK$73.46-18.97%
2009-HK$90.65-63.64%
2008-HK$249.293.57%
2007-HK$240.70-60.56%
2006-HK$610.3497.22%
2005-HK$309.47-2.7%
2004-HK$318.06-45.59%
2003-HK$584.55-61.8%
2002-HK$1,530-25.52%
2001-HK$2,055-21.38%
2000-HK$2,61313.86%
1999-HK$2,295149.53%
1998-HK$919.8098.15%
1997-HK$464.2010.2%
1996-HK$421.22